All the news Showing 10 of 27 articles from: EpidemiologyGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Hepatitis C prevalence down by 40% since 2015 in England Keith Alcorn / 11 March 2022 The prevalence of hepatitis C in England fell by almost 40% between 2015 and 2020 and deaths due to the virus fell by 35% in the same period, the UK Health Security Agency ... 2.5 million people in Africa need urgent hepatitis B treatment Keith Alcorn / 09 December 2020 Around 2.5 million people with hepatitis B in sub-Saharan Africa already have cirrhosis and need immediate antiviral treatment, a systematic review of published studies reports this month in the journal Liver International. Approximately ... Few countries will meet 2020 target for reducing viral hepatitis deaths Keith Alcorn / 24 November 2020 Around 1.1 million deaths were caused by viral hepatitis worldwide in 2019 and deaths due to hepatitis C are still rising despite the availability of direct-acting antiviral treatment, according to analyses of ... Hepatitis C in England: deaths decline but new infections steady since 2011 Keith Alcorn / 09 June 2020 The number of people with chronic hepatitis C infection in England has fallen by 30% since 2016 due to direct-acting antiviral treatment, says Public Health England in a new report on the ... Half of people who inject drugs in Middle East have hepatitis C Keith Alcorn / 24 February 2020 Half of people who inject drugs in the Middle East and north Africa have been infected with hepatitis C, and researchers from Weill Cornell Medicine Qatar estimate that around 221,000 people who ... Global burden of deaths and liver cancer due to non-alcoholic fatty liver disease growing Keith Alcorn / 11 December 2019 Non-alcoholic fatty liver disease is a growing cause of liver cancer and death in some regions of the world, an analysis of global reporting on liver disease shows. The findings ... Hepatitis C rates in US track the opioid epidemic Liz Highleyman / 14 December 2018 Nearly 2.4 million people in the United States are living with active hepatitis C virus (HCV) infection, according to the latest data from the US Centers for Disease Control and Prevention (CDC). ... Australian experience shows high DAA uptake and rapid fall in rates of HCV viraemia among people who inject drugs Michael Carter / 26 November 2018 Providing hepatitis C virus (HCV) therapy with direct-acting antivirals (DAAs) to people who inject drugs can achieve rapid reductions in community prevalence of viraemia, according to Australian research published in the Journal of Hepatology. ... HIV and chronic HCV co-infection prevalence in England highest among MSM Michael Carter / 20 August 2018 Men who have sex with men (MSM) make up the majority of people with chronic hepatitis C virus (HCV) who have co-infection with HIV, according to data from Public Health England (PHE) published ... Hepatitis C in England: 2018 report Keith Alcorn / 03 April 2018 Liver-related deaths and liver transplants due to hepatitis C are continuing to decline in England as the number of people treated with direct-acting antivirals (DAAs) rises, according to Public Health ... ← First123Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Transfusion and medical procedures Injecting drug use Mother to child Sexual transmission Non-medical blood transfer HBV vaccination Epidemiology Screening and testing policy Health services, policy and advocacy Social issues Conference news Email bulletin archive